VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IMS 2022 | The role of APOBECs in myeloma & incorporating APOBECs in current risk stratification models

Florian Kuchenbauer, MD, PhD, BC Cancer, Vancouver, Canada, comments on the role of APOBECs in multiple myeloma, highlighting how the inclusion of APOBECs into current risk stratification models can help better stratify patients with multiple myeloma, and discussing the impact of APOBECs in inflammation. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter